GeneDx Holdings Corp. financial data

Symbol
WGS, WGSWW on Nasdaq
Industry
Services-Health Services
Location
333 Ludlow Street, North Tower, 8 Th Floor, Stamford, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Sema4 Holdings Corp. (to 1/5/2023), CM Life Sciences, Inc. (to 7/21/2021)
Latest financial report
Q1 2024 - Apr 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 279 % +47.1%
Quick Ratio 15.7 % -11.3%
Debt-to-equity 73.2 % +28.1%
Return On Equity -54.8 % +54.2%
Return On Assets -31.6 % +58.5%
Operating Margin -60.4 % +78.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.1 M shares -96.7%
Common Stock, Shares, Outstanding 26.1 M shares +7.97%
Entity Public Float 96 M USD -56%
Common Stock, Value, Issued 2 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.1 M shares +29.9%
Weighted Average Number of Shares Outstanding, Diluted 26.1 M shares +29.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 222 M USD -0.91%
Research and Development Expense 55.2 M USD -30.5%
Selling and Marketing Expense 63.6 M USD -42.1%
General and Administrative Expense 113 M USD -47.2%
Operating Income (Loss) -134 M USD +79%
Nonoperating Income (Expense) -1.99 M USD -104%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -136 M USD +76.7%
Income Tax Expense (Benefit) -861 K USD +44.2%
Net Income (Loss) Attributable to Parent -135 M USD +74.7%
Earnings Per Share, Basic -4.97 USD/shares +89.3%
Earnings Per Share, Diluted -4.97 USD/shares +89.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.7 M USD -58.6%
Marketable Securities, Current 29.2 M USD
Cash, Cash Equivalents, and Short-term Investments 114 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 32.9 M USD -12.6%
Inventory, Net 11.6 M USD -5.83%
Other Assets, Current 5.02 M USD -48.2%
Assets, Current 163 M USD -40%
Property, Plant and Equipment, Net 32.5 M USD -37%
Operating Lease, Right-of-Use Asset 26.3 M USD -20.9%
Intangible Assets, Net (Excluding Goodwill) 169 M USD -7.66%
Goodwill 181 M USD
Other Assets, Noncurrent 4.38 M USD -28.9%
Assets 395 M USD -27.6%
Accounts Payable, Current 9.48 M USD -74.3%
Accrued Liabilities, Current 11.3 M USD -59%
Contract with Customer, Liability, Current 40 K USD -91.5%
Liabilities, Current 50.7 M USD -57.4%
Deferred Income Tax Liabilities, Net 1.42 M USD -43.5%
Operating Lease, Liability, Noncurrent 44.4 M USD -0.09%
Other Liabilities, Noncurrent 20.8 M USD -5.77%
Liabilities 187 M USD -13.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 291 K USD
Retained Earnings (Accumulated Deficit) -1.32 B USD -11.4%
Stockholders' Equity Attributable to Parent 207 M USD -36.9%
Liabilities and Equity 395 M USD -27.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.4 M USD +70.5%
Net Cash Provided by (Used in) Financing Activities -438 K USD -100%
Net Cash Provided by (Used in) Investing Activities 843 K USD
Common Stock, Shares Authorized 1 B shares 0%
Common Stock, Shares, Issued 26.1 M shares +7.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16 M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.7 M USD -60.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.02 M USD +246%
Deferred Tax Assets, Valuation Allowance 272 M USD +19.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 326 M USD +16.2%
Operating Lease, Liability 46.8 M USD -0.25%
Depreciation 19.7 M USD -60.6%
Payments to Acquire Property, Plant, and Equipment 443 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.4 M USD +66.6%
Lessee, Operating Lease, Liability, to be Paid 66.8 M USD -16.6%
Property, Plant and Equipment, Gross 78.9 M USD -48.4%
Operating Lease, Liability, Current 2.33 M USD -3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.21 M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.39 M USD -4.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -14.5%
Deferred Income Tax Expense (Benefit) -1.09 M USD +97.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20 M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.3 M USD +5.78%
Deferred Tax Assets, Operating Loss Carryforwards 258 M USD +29.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 942 K USD
Current Income Tax Expense (Benefit) 164 K USD +128%
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 718 K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.27 M USD +2.67%
Operating Lease, Payments 5.48 M USD +31.1%
Additional Paid in Capital 1.53 B USD +0.89%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 16.3 M USD -66.9%
Deferred Tax Assets, Net of Valuation Allowance 54.9 M USD +1.1%
Share-based Payment Arrangement, Expense -825 K USD -103%
Deferred State and Local Income Tax Expense (Benefit) -2.03 M USD +75.5%
Interest Expense 3 M USD +0.47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%